MedPath

Fluoroscopic &Ultrasonographic Guidance of Superior Hypogastric Plexus Neurolysis in Intractable Pelvic Pain

Not Applicable
Completed
Conditions
Intractable Pelvic Cancer Pain
Interventions
Procedure: double modality (ultrasound and fluroscopic) guided block
Procedure: fluroscopic guided block
Registration Number
NCT03606811
Lead Sponsor
Assiut University
Brief Summary

fluoroscopic group \& includes 30 patients where SHPB will be done Fluoroscopic-guided (the posterior oblique trajectory technique.the double modality group \& includes 30 patients where SHPB will be done using our described new technique of performing the modified Mishra technique by injecting 3-5 ml of contrast media (lohexol=omnipaque) after getting the target position.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age > 18 years.
  • Intractable pelvic cancer pain (VAS > 40 mm)
  • Pain is refractory to pharmacotherapy (both opioids and adjuvant therapy) or opioids' side effects are not tolerated.

Exclusion criteria

  • Local or systemic sepsis.
  • Uncorrectable coagulopathy.
  • Neuropsychiatric illness.
  • History of drug abuse.
  • Pregnant or lactating patients.
  • Distorted local anatomy.
  • Patients who are known to be allergic to the used medications.
  • Cardiovascular or respiratory instability.
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
double modality guided blockdouble modality (ultrasound and fluroscopic) guided block-
fluroscopic guided blockfluroscopic guided block-
Primary Outcome Measures
NameTimeMethod
pain relief will be assessed by VAS12 weeks

pain relief will be assessed by VAS (visual Analogue score) which is 100 mscale with left (0) end means no pain \& right (10) end means the worst possible pain

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NCI, Cairo university

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath